Irinotecan vs non‐irinotecan‐containing regimens
Tumour response · people with advanced gastric cancer
It is very uncertain whether irinotecan changes tumour response ‐ Other comparisons compared with non‐irinotecan‐containing regimens (very low certainty).
1 finding from 1 review
- OR 1.87 [0.89, 3.91]2 studies · 165 participantsVery low